Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Apraxia is a neurological disorder that affects the mental processes involved in planning, task performance, and more. Ataxia is a neurological sign affecting muscle coordination and movement.
Cerebellar ataxia results from dysfunction of the cerebellum, which is part of the brain that helps regulate and control movement and balance. People may experience changes in gait, speech, and eye ...
MyChesCo on MSN
Larimar Reports Promising Friedreich’s Ataxia Data as Nomlabofusp Nears Phase 3 Launch
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced third-quarter 2025 financial results and a clinical ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
The US Food and Drug Administration (FDA) has rejected PTC Therapeutics’ new drug application (NDA) for vatiquinone in Friedreich's Ataxia. This follows the biotech’s decision to submit the ...
Quince Therapeutics is advancing eDSP for Ataxia-Telangiectasia, leveraging strong prior data in the 6-9 age group and an innovative AIDE platform. Recent insider buying, new analyst coverage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback